SAP30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.65010235978025E-13 |
Normal-vs-Stage2 |
5.771700E-04 |
Normal-vs-Stage3 |
4.806400E-04 |
Normal-vs-Stage4 |
1.357660E-02 |
Stage1-vs-Stage2 |
7.195400E-01 |
Stage1-vs-Stage3 |
4.531200E-01 |
Stage1-vs-Stage4 |
5.862800E-01 |
Stage2-vs-Stage3 |
8.144200E-01 |
Stage2-vs-Stage4 |
8.118800E-01 |
Stage3-vs-Stage4 |
9.804600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
1.25669999995193E-06 |
Normal-vs-Asian |
1.053980E-01 |
Caucasian-vs-AfricanAmerican |
8.426600E-01 |
Caucasian-vs-Asian |
4.727200E-01 |
AfricanAmerican-vs-Asian |
6.513400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.82249992874972E-10 |
Male-vs-Female |
9.571700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.02420000048076E-07 |
Normal-vs-Extreme_Weight |
1.01070041225171E-10 |
Normal-vs-Obese |
2.2992718839987E-13 |
Normal-vs-Extreme_Obese |
1.753590E-02 |
Normal_Weight-vs-Extreme_Weight |
9.283800E-01 |
Normal_Weight-vs-Obese |
8.006200E-01 |
Normal_Weight-vs-Extreme_Obese |
3.101800E-03 |
Extreme_Weight-vs-Obese |
6.724000E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.075820E-03 |
Obese-vs-Extreme_Obese |
2.613300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.627610E-04 |
Normal-vs-Age(41-60Yrs) |
1.55431223447522E-15 |
Normal-vs-Age(61-80Yrs) |
2.79120060397986E-11 |
Normal-vs-Age(81-100Yrs) |
7.296700E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.188400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.673800E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.469200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.124100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.491400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.352000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
<1E-12 |
Normal-VS-Type2 PRCC |
1.90479999995219E-06 |
Normal-VS-KIRP CIMP |
2.555400E-04 |
Normal-VS-Unclassified PRCC |
3.35290000208488E-08 |
Type1 PRCC-VS-Type2 PRCC |
5.513800E-01 |
Type1 PRCC-VS-KIRP CIMP |
3.197700E-03 |
Type1 PRCC-VS-Unclassified PRCC |
9.872400E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.504200E-02 |
Type2 PRCC-VS-Unclassified PRCC |
6.085800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.865000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.1939999994558E-07 |
Normal-vs-N1 |
3.42689999999202E-06 |
Normal-vs-N2 |
4.16889966992073E-10 |
N0-vs-N1 |
2.494600E-01 |
N0-vs-N2 |
1.405180E-01 |
N1-vs-N2 |
3.507800E-01 |
|
|